Total Funding
60
77
Total FundingGrant raised
Growth Score 60 in past quarter
-1 pts
Heat Score 77 in past quarter
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
30327
AIGEN Sciences is a AI drug discovery company that combines human scientific expertise with advanced AI systems.
- Soojung Lee: Chief Operating OfficerPast Role: AIGEN Sciences, Chief Strategy Officer
- Jaewoo Kang: Founder and Chief Executive Officer
About the Company
AIGEN Sciences is an AI drug discovery platform that provides drug research and development services. The company's mission is to accelerate the development of life-saving therapies by combining deep scientific expertise with autonomous AI systems. Through a human-in-the-loop approach, we empower researchers to collaborate with intelligent
agents - amplifying decision-making, eliminating inefficiency, and delivering better medicines, faster. Its platform uses biomedical large language models, molecular design AI, and multi-omics analysis to identify and optimize drug candidates faster than traditional R&D methods.